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http:WHAT THIS PAPER ADDS
This study demonstrates that preservation of the ﬁrst covered stent used as a “neo-neck” for proximal anas-
tomosis during surgical conversion for EVAR with suprarenal ﬁxation is feasible and durable. It may represent
not only a valid and simple alternative to complete explantation in elective cases, but also as the eventual
bailout maneuver in case of emergency.Objectives: Conversion of a previous endovascular aneurysm repair (EVAR) with suprarenal ﬁxation is a
challenging situation even in the elective setting. The outcomes of a technique based on preservation of the ﬁrst
proximal covered stent of the endograft, used as a “neo-neck” for proximal anastomosis, are presented.
Methods: From 2001 to 2014, nine patients underwent elective conversion of a previous suprarenally ﬁxed EVAR.
After supraceliac clamping, the aneurysm sac was opened and the endograft identiﬁed; the fabric was cut beyond
the ﬁrst covered stent together with its native aortic wall in order to create a “neo-neck.” An aortic balloon was
inﬂated into the visceral aorta to avoid back bleeding. A Dacron bifurcated tube graft (Intergard, Maquet) was
then sutured to the neo-neck mimicking endobanding, passing the stitches into the aortic wall and the ﬁrst
covered stent.
Results: The mean age was 68 years (range, 52e84 years). The stent grafts removed were four Zenith (Cook
Medical), three Endurant (Medtronic), and two E-vita (Jotec). The indication for conversion was type 1A (n ¼ 2),
type 2 (n ¼ 2), and type 3 (n ¼ 1) endoleak, complete endograft thrombosis (n ¼ 2), and abdominal pain with sac
enlargement with no radiological sign of endoleak (n ¼ 2). Blood loss was 1,428 mL (range 500e3,000 mL); the
visceral ischemic time to perform the proximal anastomosis was 23.5 min  2.3 min). The post-operative
complication rate was 11% (n ¼ 1/9) related to a case of sac wall bleeding requiring re-intervention; mortality at
30 days was 0%. At 22 months (range, 8e41) the computed tomography angiogram demonstrated no signs of
leaks or anastomotic pseudoaneurysm.
Conclusion: Preservation of the proximal covered stent of an endograft with suprarenal ﬁxation used as an
infrarenal “neo-neck” with incorporation of the aorta to the suture line during elective surgical explantation
simpliﬁes the procedure, and can be achieved with very low early morbidity and mortality; furthermore, it seems
to be durable over mid-term follow up.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Nowadays, endovascular aneurysm repair (EVAR) is a well
established technique for abdominal aortic aneurysm (AAA)
treatment, and it has been proven to be safe and effective
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//dx.doi.org/10.1016/j.ejvs.2015.03.027outcomes may be limited by a higher rate of complications
than open repair.
Although many of these complications are successfully
addressed by endovascular means, the rate of late open
conversion in both emergent and elective settings varies
from 0% to 9% depending on different EVAR series.3,6e8 The
risk increases over time.
The overall average mortality rate associated with
explantation of an endograft is about 22%,9 ranging from
3.3% in elective cases to 25e67% in an urgent setting
(rupture or infection).10
Even if conversion in an elective setting is considered to
have low mortality, the procedure is challenging and out-
comes are also determined by the reason for conversion,
Figure 1. (A) The “neo-neck” (ﬁrst covered stent and infrarenal aortic wall) used as the site for the proximal anastomosis with the Dacron
graft, sutured in an end to end fashion, passing the stitches into the aortic wall and through the ﬁrst covered stent; the aortic balloon is
inﬂated at the level of the visceral aorta to avoid back bleeding. (B) In all the cases the stitches were passed as deeply as possible into the
aorta at the level of the bottom of the fabric covered stent mimicking endobanding.
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ﬁxation), eventual visceral ischemia time, and risk of arterial
wall damage after complete removal. Proximal11 or distal
endograft stent preservation where possible has already
been described, with a reported peri-operative morbidity
rate signiﬁcantly lower than complete endograft removal
(13% vs. 67%).12
In particular, in cases of conversion with suprarenal ﬁx-
ation, proximal endograft preservation may be necessary.
The suprarenal uncovered stent is often totally incorporated
into the aortic wall and attempts to completely remove it
may turn the operation into a high risk procedure with
increased peri- and post-operative complication rates.
Because of the low number of cases with proximal stent
preservation, there are few data on peri-operative results
and long-term follow up concerning residual proximal aortic
wall neck aneurysmal progression. The early and mid-term
outcomes with elective late conversion of AAA stent
grafts with suprarenal ﬁxation applying routine preservation
of the proximal covered stent used as infrarenal “neo-neck”
for proximal anastomosis were reviewed.
MATERIALS AND METHODS
A retrospective review was performed of all consecutive
patients admitted to the Clinic of Vascular and Endovascular
Surgery of Padova University who had undergone EVAR for
infrarenal AAAs between January 2001 and January 2014.
Informed consent requirements were waived for this study.
Only patients treated for late elective open conversion of
suprarenally ﬁxed EVAR devices were included; exclusion
criteria were emergent setting, suspicion or evidence of
infection, or infrarenal ﬁxation. Late conversion was deﬁned
as graft removal >1 month after implantation of an
endograft.
From 543 standard EVARs 11 open conversions (2 early; 9
late) were identiﬁed; additionally, another seven late open
conversions for EVAR cases previously treated at another
institution were also performed. Of the 16 late conversions,12 were elective and four were urgent (3 rupture, 1 infec-
tion); of the 12 late elective conversions, only nine were for
endografts with suprarenal ﬁxation, and these were
included in this study.
Demographics, pre-operative medical and anatomical
characteristics, and peri- and post-operative outcomes were
analyzed; particular attention was given to the time be-
tween EVAR and conversion, intra-operative blood loss,
operative time, and visceral ischemia time. Follow up data
were obtained by review of the patients’ medical records,
computed tomography (CT) angiograms, and invasive diag-
nostic studies. The operative comorbidity risk was evaluated
using the Society for Vascular Surgery (SVS) comorbidity
grading system13 and the American Society of Anesthesiol-
ogists (ASA) score. Pre-existing renal insufﬁciency was
deﬁned as serum creatinine concentration >1.5 mg/dL.
Surgical technique
Under general anesthesia all patients underwent a midline
transperitoneal surgical approach; proximal supraceliac
aortic and distal iliac control were identiﬁed by standard
access. Subsequently, the infrarenal aortic neck up to the
level of the lowest renal artery, often characterized by a
wide inﬂammatory response, was identiﬁed but not
completely dissected. Supraceliac and iliac cross-clamping
were performed; the aneurysm sac was opened through a
longitudinal arteriotomy with identiﬁcation of the endog-
raft. The arteriotomy was rapidly extended cranially until
the ﬁrst covered stent of the endograft was visualized; at
this point both the aortic wall and the endograft were
transected at the level of the fabric between the ﬁrst and
the second covered stents in order to create a “neo-neck.”
To avoid back bleeding from visceral arteries, a compliant
Reliant balloon (Medtronic, Watford, UK) was pre-inserted
through a limb of the Dacron graft to be sutured (Inter-
gard Silver, Maquet, Sunderland, UK) coming out from the
top of the graft body, and quickly advanced through the
“neo-neck” into the visceral aorta and then inﬂated there.
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the sac. The “neo-neck” at this point was used as the site for
the proximal anastomosis with the Dacron graft, sutured in
an end-to-end fashion, passing the stitches into the aortic
wall and through the ﬁrst covered stent in order to mini-
mize the risk of late dilatation of the residual aortic wall
(Fig. 1A). In all cases the stitches were passed as deeply as
possible as far as the juxtarenal aorta and through the
covered stent mimicking endobanding (Fig. 1B). Once the
proximal anastomosis was completed the Reliant balloon
was deﬂated and removed, and the clamp moved from the
supraceliac aorta to the infrarenal Dacron graft body. The
bifurcated tube graft was sewn distally at iliac level ac-
cording to the individual anatomic morphology and surgeon
preference. The external and internal iliac vessels were
dissected and controlled; when the graft was well incor-
porated into the vessel wall the distal portion of the stent
was preserved.
Post-operatively the patient was routinely observed for
the ﬁrst 24 hours in the ICU (Intensive Care Unit) and when
appropriate transferred to the Vascular Unit. Follow up
consisted of a CT scan performed before discharge, at 6
months, and annually thereafter. Fig. 2AeC shows the re-
sults of the CT angiogram for the three different types of
endograft.
RESULTS
Of the nine patients treated for late elective conversion
after EVAR with suprarenal ﬁxation, the stent-grafts were
four (44%) Zenith (Cook Medical, Bloomington, IN, USA),
three (33%) Endurant (Medtronic), and two E-vita (Jotec,
Hechingen, Germany). The average time from EVAR to
conversion was 57 months (range, 5e119 months) with ﬁve
out of nine patients (56%) having already undergone a
previous failed secondary endovascular re-interventions.
The mean number of previous endovascular attempts was
2.2 (range 0e4).
The mean age was 68 years (range, 52e84), with eight
men and one woman. Associated medical comorbidities
included coronary artery disease (n ¼ 4, 44%), hypertension
(n ¼ 9, 100%), hypercholesterolemia (n ¼ 4, 44%), diabetes
mellitus (n ¼ 2; 22%), and mild renal insufﬁciency (n ¼ 1,
11%); one patient had previously undergone heart trans-
plantation. The mean SVS total score was 0.9  0.4, while
the mean ASA score was 2.8  0.5.Figure 2. Three dimensional reconstruction of abdominal computed to
conversion for failed EVAR in three different endografts with suprar
anastomosis. (A) Endurant II; (B) Zenith Flex; (C) Zenith Low Proﬁle.Indications for conversion are described in Table 1. In
particular two patients with type 1A endoleak and no graft
migration were not ﬁt for endovascular repair and under-
went surgical conversion because of proximal aneurysmal
development (1 case) and insufﬁcient oversizing (1 case);
both cases presented intra-operatively with an aneurysmal
aortic neck wall (34 mm and 32 mm maximum diameter).
Two cases were due to persistent type 2 endoleaks with sac
enlargement after unsuccessful secondary endovascular re-
intervention; in these cases the decision for a complete
explantation was due, in one case to the young age of the
patient (52 years), and in one case because safe suture of
the lumbar arteries could not be guaranteed without
endograft explantation. One patient had a type 3 endoleak
and had already undergone an unsuccessful endovascular
attempt at iliac relining. Complete endograft thrombosis
occurred in two patients. Two patients were treated for
continuous sac enlargement with no clear evidence of
leakage.
Overall the intra-operative ﬁndings corresponded with
the pre-operative CT angiogram imaging in six of the nine
cases (67%), while in the remaining three other associated
endoleak types were present.
The mean operative time was 232 minutes (range 165e
330 minutes), with an estimated intra-operative blood loss
of 1.4 L (range, 500e3000). The mean visceral ischemic
time was 23.5 minutes (range, 21.2e25.8); in all cases
hemostasis of the proximal anastomosis at the time of
reperfusion was adequate with no need for additional
stitches or anastomotic reinforcement maneuver. No peri-
or post-operative deaths were registered; there were no
observed cases of major cardiac, renal, or pulmonary
complications. One patient underwent surgical
revision at 24 hours because of chronic bleeding from the
sac wall.
Minor complications included one case with slightly
elevated pancreatic enzymes which resolved spontaneously
with diet and medical therapy, three cases with ventilator
dependence for more than 24 hours, and one case of
bacteremia on blood culture with fever that resolved after 2
weeks of antibiotic therapy. Two cases (1 pre-existing
moderate renal insufﬁciency; creatinine 1.58 mg/dL)
developed post-operative worsening renal function
(>2.0 mg/dL) that was resolved within 2 weeks after
medical therapy.mography angiogram performed during follow up after late open
enal ﬁxation. White arrows indicate the site of hybrid proximal
Table 1. Indications and operative characteristics of the nine patients who underwent late elective open conversion for suprarenally ﬁxed
EVAR treated with the surgical infrarenal “neo-neck” technique.
Pts Indication Time to conversion
(months)
Endograft
explanted
Operative
time (min)
Blood
loss (mL)
Visceral ischemia
time (min)
Follow up
(months)/complications
1 E. type 1A 35 Zenith Flex 255 (PL) 1,000 26 (41)/e
2 E. type 1A 119 Endurant 165 2,000 23 (18)/e
3 E. type 2 29 E-vita 300 (RF) 3,000 26 (6)/e
4 E. type 2 110 E-vita 180 500 25 (13)/e
5 E. type 3 32 Zenith Flex 180 500 22 (8)/e
6 Thrombosis 5 Zenith LP 260 (RF) 1,500 25 (27)/e
7 Thrombosis 80 Endurant II 330 (PL) 2,300 20 (3)/e
8 Sac enlargement 58 Zenith Flex 190 800 21 (41)/e
9 Sac enlargement 56 Endurant 220 1,500 23 (41)/e
PL ¼ previous laparotomy with lysis of adhesions; RF ¼ retroperitoneal ﬁbrosis.
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stay averaged 11 days (range, 7e23 days). The CT scan
performed before discharge demonstrated complete aneu-
rysm exclusion with no signs of leakage or pseudoaneurysm
at the level of the proximal anastomosis with graft patency
in all cases.
At an average follow up of 22 months (range, 8e41
months), the CT angiogram demonstrated that the proximal
anastomosis was intact with no degeneration of the resid-
ual infrarenal aortic neck and no signs of anastomotic
pseudoaneurysm. No residual type II endoleaks were
identiﬁed.DISCUSSION
Late open conversion after previous EVAR is primarily per-
formed in an elective setting. Even if this type of inter-
vention represents a challenging situation for the surgeon,
the overall elective 30 day mortality is low in most of the
reported series in the literature (0 to <10%). Recently, Scali
et al.14 published their experience comparing open elective
conversion for type 1A endoleak and primary open repair of
juxtarenal aneurysm; in their conclusions there were no
differences in the 30 day mortality rates between the two
groups (4% for both; p ¼ 1). Mortality in this series at 30
days was 0% in line with that observed in the literature
review,12,15e25 where the overall 30 day mortality after
explantation was very low (<2%), with no signiﬁcant dif-
ference when comparing total versus partial explantation.
However, of the 107 reported elective explantations with
suprarenal ﬁxation, the only two deaths occurred in those
who had complete proximal explantation. Previous experi-
ences with endograft removal have led to a wide variety of
techniques helpful for stent graft explantation. May et al.11
used metal cutters to remove suprarenally ﬁxed stent
grafts; Kong et al.26 described a technique where the
proximal ﬁxation was compressed inside the barrel of a
20 mL syringe and subsequently removed; iced saline can
be placed on nitinol elements to help collapse the metal to
the pre-deployment state and facilitate removal from the
arterial wall. All these maneuvers are valid but might be
risky if the metal stent is completely incorporated in the
reactive intimal tissue, and aortic wall damage may occurduring any attempt at complete explantation. This aspect
raises more concern in cases with suprarenal ﬁxation.
Even if complete explantation is recommended, hybrid
reconstruction is accepted as long as the endograft portion
left in situ is not the cause of the failed EVAR. The preser-
vation of the ﬁrst proximal covered stent has already been
reported for explantation of EVAR with both infrarenal27
and suprarenal ﬁxation24; however, its use is limited to
cases with preserved proximal sealing by the endograft.
Usually the hybrid repair of the aortic neck is based on two
different approaches: one is to leave the incorporated un-
covered stent only, cutting the graft between the uncovered
and the covered stent and completing the surgical suture in
the juxtarenal aortic wall; the second option, which is only
possible in cases with no type IA endoleak, is to leave the
ﬁrst and/or the second covered stent and use the fabric
alone or with the aortic wall as an attachment site for
surgical anastomosis.
The concept of a “neo-neck” was useful in our experi-
ence, not only to reduce as much as possible the risk of
complications related to aortic wall damage, blood loss, and
visceral ischemia, but also as a simple solution for type 1A
endoleak repair, using the proximal covered stent as the site
for aortic wall ﬁxation in an endobanding prosthetic rein-
forcement for a juxtarenal surgical anastomosis.
The overall operative time was high (232 minutes) in our
experience, with a wide range (165e330 minutes). This is
not based on proximal anastomosis management but pri-
marily on the time needed for dissection in cases of re-
laparotomy or retroperitoneal ﬁbrosis (n ¼ 4/9; 44%) and
distal iliac reconstruction. Similarly, the literature shows
that open conversion after EVAR has signiﬁcantly longer
operative times than primary AAA open repair (p ¼ .03).14
On the other hand, the time needed to complete the
proximal anastomosis was a mean of 23 minutes, and no
complications related to visceral ischemia were observed
within 30 days. Clamp time in this experience was lower
than the 43 minutes reported by the large Cleveland Clinic10
report, where interventions for conversion with suprarenal
ﬁxation required signiﬁcantly longer mean visceral ischemia
than those with infrarenal ﬁxation (43 vs. 28 min; p ¼ .039).
Mean blood loss was lower than in the literature10,15,19,23
(1,428 L vs. 4,078 L), which may also be due to the tactic
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is often the case, a balloon must be placed at the level of the
visceral arteries but cannot prevent back bleeding from the
renals because a minimum space is needed for stitching of
the proximal anastomosis. In the approach reported here,
the presence of the ﬁrst covered stent, guarantees 1 or 2 cm
(depending on the endograft type) of infrarenal free “neo-
neck,” and the balloon can be inﬂated from visceral level
down to the level of the lowest renal artery with no back
bleeding and no cumbersome maneuvers needed for the
sutured anastomosis. Another option to avoid back bleeding
could be to directly clamp the infrarenal neck and the stent
graft together; this maneuver is avoided because of the
needs completely dissect the infrarenal neck which may be
involved in an inﬂammatory process; furthermore, with
infrarenal clamping the stent may be crushed and the pos-
terior suture may be difﬁcult. Overall, the early complication
rate was 11% (1 of 9 cases), and this was not related to
proximal anastomosis management but to persistent sac
bleeding; unfortunately, the literature does not provide clear
data in this regard for comparison purposes.
The major concern regarding the use of a transected
endograft as a part of the anastomosis concerns future
pseudoaneurysm of the residual diseased aortic wall.
In 2003, Lipsitz et al.12 reported a series of seven patients
who underwent partial resection with hybrid reconstruction
(proximal or distal iliac site) and no anastomotic complica-
tions at 22 months follow up. These ﬁndings are similar to
our results where no mid-term (22 months) proximal
anastomotic complications were identiﬁed in any of the
nine cases, including those treated for type IA endoleak.
In the authors’ view, this technique is simple, and, in
addition to being routinely used for elective cases, may also
represent a valid bailout approach in emergent cases pre-
senting with rupture.
This study has some limitations that are worthy of
mention. It was a retrospective observational study, with a
small number of cases. The literature review is limited by
the fact that the vast majority of reports do not clearly
deﬁne the technique utilized in hybrid proximal stent
preservation; furthermore, some fundamental information
such as operative and post-operative outcomes and early
mortality are not well stratiﬁed by the reason for
conversion.
However, the accurate selection of the patients analyzed
and the standardized technique validate the feasibility of
this approach. Finally, an overview with sufﬁcient baseline
outcomes with which to compare the results is provided.
Preserving the proximal covered stent of an endograft
with suprarenal ﬁxation and incorporating the aorta to the
suture line during elective surgical explantation simpliﬁes
the procedure, and can be achieved with very low early
morbidity and mortality; furthermore, it seems to be du-
rable over mid-term follow up.CONFLICT OF INTEREST
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